Lv2
180 积分 2023-11-25 加入
Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods
1天前
待确认
Efficacy and Safety of Iparomlimab, an Anti-PD-1 Antibody, in Patients with Advanced Solid Tumors: A Phase 1c Study
13天前
已完结
Iparomlimab and Tuvonralimab: First Approval
13天前
已完结
Initial low dose of dacomitinib for first-line treatment of patients with EGFR exon 21 mutated non-small cell lung cancer
3个月前
已关闭
Combined Radiation Therapy and Immune Checkpoint Blockade Therapy for Breast Cancer
5个月前
已完结
Immunotherapy Combined with Radiation Therapy in Breast Cancer: A Rapidly Evolving Landscape
5个月前
已完结
Effect of triple therapy with low-dose total body irradiation and hypo-fractionated radiation plus anti-programmed cell death protein 1 blockade on abscopal antitumor immune responses in breast cancer
5个月前
已完结
Radiation Therapy Sensitizes a Poorly Immunogenic Breast Cancer to PD-1 Blockade
5个月前
已完结
Hyperthermia with low-dose radiotherapy for recurrent breast carcinoma
5个月前
已完结
Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study
6个月前
已完结
皖公网安备34019202002308
